Navigation Links
ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group

MINNEAPOLIS, and BEVERLY HILLS, Calif., Aug. 5, 2014 /PRNewswire/ -- ViaDerma, Inc. (OTCQB: VDRM), a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research and development, and The Brewer Group, Inc. (TBG), a diversified global investment advisory firm, today announced a new strategic partnership. TBG will expand ViaDerma's business development and marketing efforts at home and abroad to grow interest in ViaDerma's patent-pending pharmaceutical delivery system, which allows for rapid transdermal transfer of active ingredients and immediate relief of symptoms.

ViaDerma licenses products in fields of medicine ranging from infectious disease treatments to stem-cell therapy. Pharmaceutical companies seeking more efficient methods for delivering their products to patients will have new access to solutions worldwide, as The Brewer Group, Inc. and ViaDerma, Inc. leverage TBG's vast network to pave the way for new strategic business alliances and expand the range of the breakthrough rapid delivery of nutrients and medicines using ViaDerma's technology.

ViaDerma continues to develop new applications for its trade-secret Rapid Active Ingredient Delivery System (RAIDS), and founder Dr. Christopher Otiko emphasizes its extreme versatility. "The speed of the RAIDS method for pharmaceutical distribution and the wide variety of products that can utilize it will allow medical professionals and general consumers alike to benefit from faster treatment," Dr. Otiko said. "Products using RAIDS are at the forefront of medical sophistication and nearly any drug that medical professionals can administer as a pill can utilize RAIDS for quicker delivery, from pain relievers to cosmetics. As ViaDerma, Inc. expands, our partnership with The Brewer Group will combine their experience and network with our revolutionary technologies to reach ever-larger audiences."

Using tailored business development strategies including exclusive access to its extensive network and established relationships spanning the globe, TBG will reach out to synergetic companies and partner organizations, explore licensing opportunities as well as provide ongoing marketing support and enhance global exposure for ViaDerma's unique technology.

"I'm excited to be working with an organization like ViaDerma, because their technology represents a fundamental shift in the way we should expect treatment to progress," The Brewer Group CEO H.E. Ambassador Jack Brewer said. "What if patients saw results from antibiotics after just a day of treatment, instead of a week? People would come to demand that kind of speed, and TBG is ready to connect ViaDerma Inc. with strategic partners to meet those expectations."

About ViaDerma, Inc.

ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research and development. ViaDerma licenses products in the fields of medicine ranging from infectious diseases to stem-cell therapy. Dr. Christopher Otiko is the company's founder, and ViaDerma became a publicly-traded company in 2014. For more information, go to

About The Brewer Group, Inc.

The Brewer Group (TBG) is a multi-faceted global investment advisory firm focused on providing tailored services including capital markets, asset management, specialty finance and business development for public and private companies as well as high-profile clientele. TBG leverages its relationships with key international decision-makers spanning government agencies, private equity firms, corporations, NPOs, leaders in government, and sports and entertainment to place TBG in a unique position to execute a wide range of services around the globe. For further information, please visit


SOURCE ViaDerma, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
(Date:10/12/2015)... Oct. 12, 2015 This report covers the ... cell type, products, applications, end-user markets and geographic segmentation. ... The global cell expansion market generated revenue of ... reach revenues of $9.7 billion in 2015 and $22.0 ... (CAGR) of 17.8% from 2015 to 2020. This ...
(Date:10/12/2015)... cell surface marker detection market ... to a new report by Grand View Research, Inc. This ... of oncology diseases and other cell-associated disorders. --> ... USD 6.49 billion by 2022, according to a new report ... be attributed to rise in incidence of oncology diseases and ...
(Date:10/12/2015)... CITY , Oct. 12, 2015 /PRNewswire/ - Aeterna ... specialty biopharmaceutical company engaged in developing and commercializing novel ... the departure of Dennis Turpin , the Company,s ... decision to close its Quebec City ... Chairman, President and Chief Executive Officer of the Company ...
(Date:10/12/2015)... , October 12, 2015 LabStyle ... Diabetes Management Solution, today announced its Medical Director, Dr. ... study at MobiHealth,s 5th EAI International Conference on ... healthcare through innovations in mobile and wireless technologies," the ... from October 14 - 16, 2015. The ...
Breaking Biology Technology:
(Date:10/1/2015)... 2015  Biometrics includes diverse set of technologies ... such as fingerprints, eye retinas, facial patterns, voice ... technology has been constantly increasing in ... In addition to the most prominent popular method ... means of biometric authentication are rapidly gaining traction ...
(Date:9/30/2015)... PALM BEACH GARDENS, Fla. , Sept. 30, 2015 ... Circuit earlier this month issued another key ruling in ... Commission,s (ITC,s) determination that Korean fingerprint scanner company Suprema ... the Tariff Act of 1930, a trade provision that ... connection with import trade, by infringing two of Crossmatch,s ...
(Date:9/29/2015)... , Sept. 29, 2015 News ... productivity while also saving energy , Minimized design ... Low Power Active Mode and embedded Fujitsu PalmSecure authentication ... Fujitsu today shows that good things come ... refreshed models to its enterprise desktop and mobile portfolio. ...
Breaking Biology News(10 mins):